The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement

26 Jan 2024 07:00

RNS Number : 9768A
DX (Group) PLC
26 January 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

DX (Group) plc

("DX", or the "Company")

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), DX confirms that as at the date of this announcement, it has in issue 647,199,135 ordinary shares of one penny each.

The International Securities Identification Number for DX's ordinary shares is GB00BJTCG679.

 Enquiries

DX

Paul Ibbetson, Chief Executive Officer David Mulligan, Chief Financial Officer

 

+44 20 3178 6378

(c/o KTZ Communications)

 

 

Moelis & Company UK LLP (Lead Financial Adviser to DX)

Mark Aedy, Yorick van Slingelandt, Chris Raff

 

+44 20 7634 3500

Liberum Capital Limited (Nominated Adviser and Joint Broker to DX)

Nick How

 

+44 20 3100 2000

KTZ Communications (PR Adviser to DX)

Katie Tzouliadis/Robert Morton

 

+44 20 3178 6378

Addleshaw Goddard LLP is acting as legal adviser to DX in connection with the Acquisition.

Important notices relating to financial advisers

Moelis & Company UK LLP ("Moelis"), which is regulated by the FCA in the United Kingdom, is acting exclusively for DX and no one else in connection with the Acquisition and other matters set out in this announcement and will not be responsible to anyone other than DX for providing the protections afforded to clients of Moelis, or for providing advice in connection with the Acquisition or any matter referred to herein. Neither Moelis nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Moelis in connection with this announcement, any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as nominated adviser and joint corporate broker to DX and for no one else in connection with the Acquisition or any matters referred to in this announcement and will not be responsible to anyone other than DX for providing the protections afforded to its clients nor for providing advice in relation to the Acquisition, the contents of this announcement or any other matters referred to in this announcement. Neither Liberum nor any of its affiliates, respective directors, officers, employees and agents owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person other than DX in connection with the matters referred to in this announcement, or otherwise.

Further information

This announcement is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise.

The Acquisition is subject to English law and to the applicable requirements of the Code, the Panel, AIM Rules, the London Stock Exchange and the FCA.

The Acquisition is made solely by the Scheme Document (or, in the event that the Acquisition is implemented by means of a Takeover Offer, the Offer Document), which, together with the Forms of Proxy, contains the full terms and conditions of the. DX Shareholders are advised to read the formal documentation in relation to the Acquisition carefully. Each DX Shareholder is urged to consult their independent financial adviser regarding the tax consequences of the Acquisition.

This announcement does not constitute a prospectus or a prospectus equivalent document.

If you are in any doubt about the Acquisition, the contents of the Scheme Document or as to the action you should take, you are recommended to seek your own personal financial, tax and/or legal advice immediately from your stockbroker, bank manager, solicitor, accountant, or other independent financial adviser authorised under the Financial Services and Markets Act 2000, if you are in the United Kingdom, or, if not, from another appropriately authorised independent adviser in the relevant jurisdiction.

Overseas jurisdictions

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are not resident in the United Kingdom or who are subject to the laws of any jurisdiction other than the United Kingdom (including Restricted Jurisdictions) should inform themselves about, and observe, any applicable legal or regulatory requirements. Any failure to comply with applicable legal or regulatory requirements of any jurisdiction may constitute a violation of securities laws or regulations in that jurisdiction. To the fullest extent permitted by applicable law or regulations, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person.

This announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England.

The Acquisition will not be made, directly or indirectly, in or into or by use of the mails or any other means or instrumentality (including, without limitation, telephonic or electronic) of interstate or foreign commerce of, or any facility of a national, state or other securities exchange of, a Restricted Jurisdiction, and the Acquisition will not be capable of acceptance by any such use, means, instrumentality or facility or from within a Restricted Jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction or any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction.

Further details in relation to DX Shareholders in overseas jurisdictions are contained in the Scheme Document.

Rounding

Certain figures included in this announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of figures that precede them.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTVELFLZFLBBBV
Date   Source Headline
15th Dec 20227:00 amRNSAGM Statement
14th Dec 202210:45 amRNSAmendment to Performance Share Plan
12th Dec 20227:00 amRNSDX opens new depot in Plymouth
30th Nov 20222:44 pmRNSDirector/PDMR Shareholding, Issue of Equity, TVR
28th Nov 20227:00 amRNSDX investing £3.6m in depot upgrades
21st Nov 20229:57 amRNSPublication of ARA and Notice of AGM
17th Nov 20224:46 pmRNSPDMR Shareholding, Issue of Equity and TVR
15th Nov 20227:26 amRNSAppointment of Executive Chairman
15th Nov 20227:00 amRNSFinal Results
15th Nov 20227:00 amRNSRetirement of Chairman
7th Nov 20227:00 amRNSDX launches the first of eight new Parcel depots
26th Oct 20225:11 pmRNSReceipt of Requisition Notice
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:35 pmRNSPrice Monitoring Extension
20th Oct 20222:27 pmRNSResult of General Meeting
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:36 pmRNSPrice Monitoring Extension
19th Oct 20222:06 pmRNSSecond Price Monitoring Extn
19th Oct 20222:00 pmRNSPrice Monitoring Extension
19th Oct 202211:05 amRNSSecond Price Monitoring Extn
19th Oct 202211:00 amRNSPrice Monitoring Extension
19th Oct 20227:30 amRNSRestoration - DX (Group) plc
19th Oct 20227:00 amRNSRestoration of Listing,Board Change,Results Notice
17th Oct 20227:00 amRNSLaunch of electric fleet for Lonon eliveries
17th Oct 20227:00 amRNSLaunch of electric fleet for London deliveries
12th Oct 20225:53 pmRNSBoard Change
5th Oct 20227:00 amRNSLaunches £750K electric vehicle project with IKEA
28th Sep 20227:00 amRNSHalf-year Results
28th Sep 20227:00 amRNSCapital Allocation Policy Review
20th Sep 20227:01 amRNSPublication of FY2021 Annual Report & Accounts
20th Sep 20227:00 amRNSConclusion of Corporate Governance Investigation
14th Sep 20227:00 amRNSNew Depot Openings in Paisley and West Bromwich
6th Sep 20229:09 amRNSBoard Change
12th Jul 20227:00 amRNSBoard Appointments
7th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSUpdate re Corporate Governance Inquiry
14th Jun 20227:00 amRNSAppointment of Auditor
10th May 20227:00 amRNSUpdate regarding appointment of an auditor
14th Mar 20227:00 amRNSOpening of New Dartford Depot
17th Feb 202212:48 pmRNSPosting of Notice to Members
9th Feb 20227:00 amRNSLaunch of Exchange Portal
4th Feb 202211:59 amRNSResignation of Auditor - Replacement
4th Feb 20227:00 amRNSResignation of Auditor
2nd Feb 20227:00 amRNSTrading update
1st Feb 20229:55 amRNSBoard changes
5th Jan 20227:00 amRNSExpansion of Delivery Network with Two New Depots
4th Jan 20227:30 amRNSSuspension - DX (Group) PLC
4th Jan 20227:00 amRNSSuspension of Trading on AIM
21st Dec 20217:00 amRNSReview of Growth Strategy and Capital Allocation
16th Dec 20218:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.